Web Results

OSI Pharmaceuticals - Wikipedia

en.wikipedia.org/wiki/OSI_Pharmaceuticals

OSI Pharmaceuticals, Inc. is an American pharmaceutical company based in Long Island, New York with facilities in Colorado, New Jersey and the United ...

Astellas Pharma US, Inc. | R&D

www.astellas.us/therapeutic/rnd/

Agensys, Inc., a subsidiary of Astellas Pharma Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers.

Astellas buys OSI Pharma for $4 billion in cancer push | Reuters

www.reuters.com/article/us-osi-astellas-idUSTRE64G06J20100517

May 17, 2010 ... Astellas Pharma (4503.T), Japan's No. 2 drugmaker, agreed to buy U.S. biotech OSI Pharmaceuticals OSIP.O for $4 billion in cash in a ...

OSI Pharmaceuticals LLC :: Scrip

scrip.pharmamedtechbi.com/companies/_id240

Roche and OSI Pharmaceuticals to pay $67m to resolve claims they misrepresented Tarceva effectiveness, diverting patients from first-line treatments and ...

Astellas Pharma Inc Shuts Down OSI Pharmaceuticals Inc Perseid in ...

www.biospace.com/News/astellas-pharma-inc-shuts-down-osi-pharmaceuticals/296532

May 14, 2013 ... Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Reshaping Research Framework to Enhance the ...

OSI Pharmaceuticals Inc.: Private Company Information - Bloomberg

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=293711

As of May, 2013, OSI Pharmaceuticals Inc. went out of business. OSI Pharmaceuticals Inc. offers oncology drug discovery and translational research services ...

OSI Pharmaceuticals Acquires Oncology Assets from Gilead Sciences

www.gilead.com/news/press-releases/2001/11/osi-pharmaceuticals-acquires-oncology-assets-from-gilead-sciences

OSI Pharmaceuticals (Nasdaq: OSIP) and Gilead Sciences (Nasdaq: GILD) today announced that they have signed an agreement, valued at up to $200 million ...

OSI Pharmaceuticals Announces Acceptance of a Tarceva(R ...

www.us.astellas.com/docs/us/OSIP_News_2009_7_6_General_Releases.pdf

OSI Pharmaceuticals Announces Acceptance of a Tarceva(R) Supplemental New Drug. Application in Pancreatic Cancer for Review by the U.S. Food and Drug ...

OSIP - Yahoo Finance

finance.yahoo.com/q?s=OSIP

Previous Close, N/A. Open, N/A. Bid, N/A x N/A. Ask, N/A x N/A. Day's Range, N/A - N/A. 52 Week Range, undefined - undefined. Volume, N/A. Avg. Volume, N/A ...

Astellas Completes Acquisition of OSI Pharmaceuticals - PR Newswire

www.prnewswire.com/news-releases/astellas-completes-acquisition-of-osi-pharmaceuticals-95936249.html

Jun 9, 2010 ... TOKYO, June 9 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) announced today that the company has completed its acquisition of OSI ...

More Info

OSI Pharma, Long Island Biotech Bellwether, Shut Down by Astellas ...

www.xconomy.com

May 14, 2013 ... OSI Pharmaceuticals became the home-grown beacon of Long Island, NY's biotech scene behind the lung cancer drug erlotinib (Tarceva), ...

Astellas Pharma US | LinkedIn

www.linkedin.com

Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Located in Northbrook, Illinois, the company serves as the headquarters for the ...

Genentech: Press Releases | OSI Pharmaceuticals and Genentech ...

www.gene.com

Jun 16, 2004 ... OSI Pharmaceuticals and Genentech Enter into Co-Promotion and Manufacturing Agreements for Tarceva. Melville, N.Y. and South San ...